Related Experiment Video

Updated: Jul 4, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Targeting mutant p53 shows promise for sunscreens and skin cancer

Wafik S El-Deiry1

  • 1Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. wafik@mail.med.upenn.edu

The Journal of Clinical Investigation
|December 7, 2007
PubMed

Insights

A drug targeting mutant p53 protein, CP-31398, effectively treats and prevents UVB-induced skin cancer in mouse models and human cells. This finding offers new strategies for skin cancer chemoprevention and therapy.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Chronic ultraviolet (UV) light exposure is a significant risk factor for skin cancer development.
  • UV radiation induces DNA damage, leading to mutations in the p53 tumor suppressor gene, a key event in cancer progression.
  • Mutant p53 proteins contribute to the development and maintenance of various cancers.

Purpose of the Study:

  • To investigate the therapeutic and preventative potential of the mutant p53 conformation-modifying drug CP-31398.
  • To evaluate the efficacy of CP-31398 in a non-immunodeficient mouse model of UVB-induced skin cancer.
  • To assess the drug's effects on human skin carcinoma cells harboring mutant p53.

Main Methods:

  • Utilized a non-immunodeficient mouse model exposed to chronic UVB radiation to induce skin cancer.
  • Treated established UVB-induced skin tumors and assessed tumor prevention with CP-31398.
  • Examined the effects of CP-31398 on human skin carcinoma cells with mutant p53.

Main Results:

  • The drug CP-31398 demonstrated significant efficacy in treating existing UVB-induced skin tumors in mice.
  • CP-31398 also showed a preventative effect, reducing the incidence or progression of skin tumors.
  • The drug's activity was observed in both the preclinical mouse model and human skin carcinoma cells.

Conclusions:

  • The mutant p53-targeting drug CP-31398 is a promising agent for both the treatment and prevention of skin cancer.
  • These findings have significant implications for developing novel chemoprevention strategies for common mutant p53-driven tumors.
  • CP-31398 represents a potential therapeutic avenue for managing skin cancers characterized by p53 mutations.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...